Correlation Between Platelets Count, Platelet Index and D-Dimer in Covid-19 Patients
DOI:
https://doi.org/10.18196/mmjkk.v23i1.16121Keywords:
COVID-19, D-Dimer, platelets, platelet indexAbstract
Hypercoagulation in the alveoli of the lungs is one of the causes of death in SARS-CoV2 virus infection. Hypercoagulation is defined by an elevation in D-Dimer, which typically rises on the fifth day of therapy. This parameter is not available in all hospitals and is still relatively expensive in preventing premature death. Platelets count and indices are suggested to describe the thromboinflammatory condition in COVID-19 patients. This research is an observational analytic study with a cross-sectional study design in 59 COVID-19 patients treated at Hassanuddin University Hospital. The patients who are declared COVID-19 based on the results of radiological examinations and PCR swabs underwent routine blood tests and D-Dimer before undergoing therapy. Data were analyzed using the Spearmen test in SPSS version 26 to reveal the correlation between platelet count, platelet indices, and D Dimer in COVID-19 patients with severe and non-severe conditions. Platelet count, platelet indices, especially MPV, and D-Dimer values were found to correlate in both groups COVID-19 using the Spearman rho correlation test (p < 0.000) with strengths correlation between -44.6 and 60.5. There was a significant association between platelet count and MPV value with D-Dimer in COVID-19 patients.References
Hong ZS, Tan YY, Chen SD, Jin HJ, Guo YR, Cao Qing D, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. https://doi.org/10.1186/s40779-020-00240-0
Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, et al. Coronavirus diseases (COVID-19) current status and future perspectives: A narrative review. Int. J Environ Res Public Health. 2020;17(8):E2690. https://doi.org/10.3390/ijerph17082690
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25. https://doi.org/10.1016/j.jinf.2020.04.021
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J. 2020;55(5):2000547. https://doi.org/10.1183/13993003.00547-2020
Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of haemostasis disorders in critically ill patients with COVID-19. Intensive Care Med. 2020;46(8):1603-1606. https://doi.org/10.1007/s00134-020-06088-1
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417- 1418. https://doi.org/10.1016/S0140-6736(20)30937-5
Ullah W, Saeed R, Sarwar U, Patel R, Fischman DL. COVID-19 Complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure. JACC Case Rep. 2020;2(9):1379-1382. https://doi.org/10.1016/j.jaccas.2020.04.008
Li C, Li J, Ni H. Crosstalk Between Platelets and Microbial Pathogens. Front Immunol 2020; 11: 1962. https://doi.org/10.3389/fimmu.2020.01962
Assinger A. Platelets and infection an emerging role of platelets in viral infection. Front Immunol 2014; 5: 649. https://doi.org/10.3389/fimmu.2014.00649
Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pão CRR, et al. Platelet activation and platelet-monocyte aggregates formation trigger tissue factor expression in severe COVID-19 patients. Blood 2020; 136: 1330-1341. https://doi.org/10.1182/blood.2020007252
Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. E Clinical Medicine 2020: 100434. https://doi.org/10.1016/j.eclinm.2020.100434
Yao Y, Cao J, Wang Q, Liu K, Luo Z, Yu K, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. Crit Care Emerg Med. 2020;8:49. https://doi.org/10.1186/s40560-020-00466-z
Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, et al. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb Res. 2020; 196: 99–105. https://doi.org/10.1016/j.thromres.2020.08.032
Poudel A, Yashasa P, Anurag A, Barun B, Debika D, Tamanna B, et al. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. Nepal : A retrospective study. PLoS ONE 16(8): e0256744. https://doi.org/10.1371/journal.pone.0256744
Yardimci AC, Yildiz S, Ergen E, Balli H, Ergene E, Balli H, et al. Association between platelet indices and the severity of the disease and mortality in patients with COVID-19. Retrospective Study. European Review for Medical and Pharmacological Sciences. 2021; 25: 6731-6740. https://doi.org/10.26355/eurrev_202111_27118
Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multi-organ response. Curr Probl Cardiol. 2020:100618. https://doi.org/10.1016/j.cpcardiol.2020.100618
Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438-e440. https://doi.org/10.1016/S2352-3026(20)30145-9
Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G. Hyperinflammation and dearangement of renin- angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020;507:167-173. https://doi.org/10.1016/j.cca.2020.04.027
Fogarty H, Townsend L, Cheallaigh CN, Bergin C, Martin-Loeches I, Browne P, et al. More on COVID-19 coagulopathy in Caucasian patients. Br J Haematol. 2020;186(6):1060-1061. https://doi.org/10.1111/bjh.16749
Geoffrey DW, Jonathan LM. The Impact of COVID-19 Disease on Platelets and Coagulation. Chicago Pathobiology 2021;88:15–27. https://doi.org/10.1159/000512007
Fan BE, Ng J, Chan SSW, Christopher D, Tso ACY, Ling LM, et al. COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. J Thromb Thrombolysis. 2021; 51(3): 663–674. https://doi.org/10.1007/s11239-020-02318-x
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020 Jun;127:104370. https://doi.org/10.1016/j.jcv.2020.104370
Hille L, Lenz M, Vlachos A, Grüning B, Hein L, Neumann FJ, et al. Ultrastructural, transcriptional, and functional differences between human reticulated and non-reticulated platelets. J Thromb Haemost. 2020 Aug;18(8): 2034–46. https://doi.org/10.1111/jth.14895
Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y. et al. SARS- CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol 2020; 13: 120. https://doi.org/10.1186/s13045-020-00954-7
Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao S, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020 May;31(4):490–6. https://doi.org/10.1080/09537104.2020.1754383
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205-1208. https://doi.org/10.1007/s00277-020-04019-0
Helms J, Tacquard C, Severac F, Leonard-Lo- rant I, Ohana M, Delabranche X, et al. CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun;46(6):1089–98. https://doi.org/10.1007/s00134-020-06062-x
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-1424. https://doi.org/10.1111/jth.14830
Zhou F, Ting Y, Ronghui D, Guohui F, Ying L, Zhibo L, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 March- April: 395 (10229: 1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3
Downloads
Published
Issue
Section
License
Copyright
Authors retain copyright and grant Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) the right of first publication with the work simultaneously licensed under an Attribution 4.0 International (CC BY 4.0) that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK).
License
Articles published in the Mutiara Medika: Jurnal Kedokteran dan Kesehatan (MMJKK) are licensed under an Attribution 4.0 International (CC BY 4.0) license. You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
This license is acceptable for Free Cultural Works. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
